Heading down and continues to make new lows. Moving opposite to the TSX, which has turned and is heading higher. Lower lows and lower highs, the definition of a downtrend. Sell your losers.
Tough. Heavy debt load with variable rate exposure. Good business. Reworking portfolio. Should be stable once they right-size balance sheet, which they're working on. He's watching it. He's not tempted to bottom-fish, wants to see a few better quarters first.
Global assets. In a tough spot. Challenges to earnings from interest rates and currency. Great assets. Not for the faint of heart. Not for him today.
It owns medical facilities globally. This includes medical office buildings, hospitals, etc. The balance sheet is a bit stretched along with an 8% yield. Another concern is some cash flow disruption due to not hedging currencies.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. NAV per unit growth is 6.3% based on strong revaluation gains in Australia and a rebound for Brazilian Real. The growth strategy based on continued revaluation gains and execution in UK value creation initiatives was reiterated by management. Deploying capital for their acquisition. A fine quarter. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A very decent REIT. They have a stable base of business with good income. Not cheap on valuation but the last quarter results were good and it has weathered the pandemic well. Unlock Premium - Try 5i Free
NorthWest Health Prop Real Est Inv Trust is a Canadian stock, trading under the symbol NWH.UN-T on the Toronto Stock Exchange (NWH.UN-CT). It is usually referred to as TSX:NWH.UN or NWH.UN-T
In the last year, 5 stock analysts published opinions about NWH.UN-T. 0 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for NorthWest Health Prop Real Est Inv Trust.
NorthWest Health Prop Real Est Inv Trust was recommended as a Top Pick by on . Read the latest stock experts ratings for NorthWest Health Prop Real Est Inv Trust.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered NorthWest Health Prop Real Est Inv Trust In the last year. It is a trending stock that is worth watching.
On 2023-05-31, NorthWest Health Prop Real Est Inv Trust (NWH.UN-T) stock closed at a price of $7.48.
We would consider results OK. Cash flow per share of 16c did miss estimates of 17c, but revenue of $135M beat estimates of $122M. Payout ratio has risen but on an annual basis was 68% in 2022. Operating income increased, offset by higher rates. Occupancy is good at 97%, leases are long and many are indexed. The convertible issue, the institutional investor and the planned asset sales should add a lot more financial flexibility. The proof will be in the pudding but the comments we think make the point that management knows that leverage and recession concerns are hurting their valuation. We are not sure the corned has been turned, but are more optimistic than pessimistic, largely because of its already-low valuation.
Unlock Premium - Try 5i Free